Cell Line : NCI-H146
Cellosaurus Index : CVCL_1473
Cellosaurus ID : NCI-H146
GDSC1 Name
, GDSC2 Name
: NCI-H146
CCLE Name
: NCIH146_LUNG
CTRP2 Name
: NCIH146
Cancer Type : lung
Dataset : All
Drug Response Information
Click to show/hide information cards below or download all drug response information.
Information cards below will change according to the dataset selected. The default dataset is “All”, which means information in the cards is based on the integration. If “All” is not selected, information cards will contain drug response information preprocessed for each dataset independently.
Experimental information
Experimental information from All dataset, including cell line name, drug name, and minimum and maximum dosages used in each experiment. Click on Dose-response to query more detail for each experiment.
| Cellosaurus ID | Drug Name | Original Dataset(s) | Min Dose | Max Dose | Dose-response |
|---|---|---|---|---|---|
| NCI-H146 | (5Z)-7-Oxozeaenol | GDSC1 | 0.0391 | 10.0000 |
|
| NCI-H146 | 1S,3R-RSL-3 | CTRP2 | 0.0010 | 33.0000 |
|
| NCI-H146 | 3-Cl-AHPC | CTRP2 | 0.0041 | 66.0000 |
|
| NCI-H146 | 5-Fluorouracil | GDSC2 | 0.0200 | 20.0000 |
|
| NCI-H146 | 965-D2 | GDSC1 | 0.0391 | 10.0000 |
|
| NCI-H146 | 993-D2 | GDSC1 | 0.0391 | 10.0000 |
|
| NCI-H146 | A-83-01 | GDSC1 | 0.0781 | 20.0000 |
|
| NCI-H146 | AA-COCF3 | CTRP2 | 0.0010 | 33.0000 |
|
| NCI-H146 | ABT737 | GDSC2,CTRP2 | 0.0011 | 37.0000 |
|
| NCI-H146 | ACY-1215 | GDSC1 | 0.0781 | 20.0000 |
|
| NCI-H146 | Afatinib | GDSC1,GDSC2 | 0.0020 | 10.0000 |
|
| NCI-H146 | Afuresertib | GDSC2 | 0.0100 | 10.0000 |
|
| NCI-H146 | AGI-5198 | GDSC2 | 0.0100 | 10.0000 |
|
| NCI-H146 | AGI-6780 | GDSC1,GDSC2 | 0.0020 | 10.0000 |
|
| NCI-H146 | AGK-2 | GDSC2,CTRP2 | 0.0010 | 33.0000 |
|
| NCI-H146 | AICA Ribonucleotide | GDSC1 | 7.8125 | 2000.0000 |
|
| NCI-H146 | Alisertib | GDSC1,GDSC2,CTRP2 | 0.0020 | 66.0000 |
|
| NCI-H146 | alisertib:navitoclax (2:1 mol-mol) | CTRP2 | 0.0015 | 50.0000 |
|
| NCI-H146 | Alpelisib | GDSC2 | 0.0100 | 10.0000 |
|
| NCI-H146 | alvocidib | CTRP2 | 0.0020 | 66.0000 |
|
| NCI-H146 | AMG-319 | GDSC2 | 0.0100 | 10.0000 |
|
| NCI-H146 | apicidin | CTRP2 | 0.0010 | 33.0000 |
|
| NCI-H146 | Apitolisib | GDSC1 | 0.0781 | 20.0000 |
|
| NCI-H146 | Ara-G | GDSC1 | 0.0781 | 20.0000 |
|
| NCI-H146 | ARRY-520 | GDSC1 | 0.0010 | 0.2560 |
|
| NCI-H146 | AST-1306 | GDSC1 | 0.0781 | 20.0000 |
|
| NCI-H146 | AT13148 | GDSC2 | 0.0080 | 8.0000 |
|
| NCI-H146 | AT13387 | CTRP2 | 0.0020 | 66.0000 |
|
| NCI-H146 | AT7867 | GDSC1 | 0.0781 | 20.0000 |
|
| NCI-H146 | austocystin D | CTRP2 | 0.0011 | 37.0000 |
|
| NCI-H146 | Avagacestat | GDSC1,GDSC2 | 0.0100 | 10.0000 |
|
| NCI-H146 | Axitinib | GDSC1,GDSC2 | 0.0078 | 10.0000 |
|
| NCI-H146 | AZ20 | GDSC1 | 0.0391 | 10.0000 |
|
| NCI-H146 | AZ6102 | GDSC2 | 0.0100 | 10.0000 |
|
| NCI-H146 | AZ960 | GDSC2 | 0.0100 | 10.0000 |
|
| NCI-H146 | AZD-7545 | CTRP2 | 0.0023 | 74.0000 |
|
| NCI-H146 | AZD1208 | GDSC1 | 0.0391 | 10.0000 |
|
| NCI-H146 | AZD1332 | GDSC1 | 0.0391 | 10.0000 |
|
| NCI-H146 | AZD1480 | GDSC1 | 0.0098 | 2.5000 |
|
| NCI-H146 | AZD2014 | GDSC1 | 0.0391 | 10.0000 |
|
| NCI-H146 | AZD3514 | GDSC1 | 0.0391 | 10.0000 |
|
| NCI-H146 | AZD3759 | GDSC2 | 0.0010 | 1.0000 |
|
| NCI-H146 | AZD4547 | GDSC1,GDSC2 | 0.0039 | 10.0000 |
|
| NCI-H146 | AZD4877 | GDSC1 | 0.0002 | 0.0390 |
|
| NCI-H146 | AZD5363 | GDSC2 | 0.0100 | 10.0000 |
|
| NCI-H146 | AZD5438 | GDSC1 | 0.0391 | 10.0000 |
|
| NCI-H146 | AZD5582 | GDSC1,GDSC2 | 0.0100 | 10.0000 |
|
| NCI-H146 | AZD6094 | GDSC1 | 0.0098 | 2.5000 |
|
| NCI-H146 | AZD6482 | GDSC1,GDSC2,CTRP2 | 0.0020 | 66.0000 |
|
| NCI-H146 | AZD6738 | GDSC1,GDSC2 | 0.0100 | 10.0000 |
|
| NCI-H146 | AZD7762 | GDSC1,GDSC2,CTRP2 | 0.0010 | 66.0000 |
|
| NCI-H146 | AZD7969 | GDSC1 | 0.0391 | 10.0000 |
|
| NCI-H146 | AZD8055 | GDSC1,CTRP2 | 0.0020 | 66.0000 |
|
| NCI-H146 | AZD8186 | GDSC1,GDSC2 | 0.0098 | 10.0000 |
|
| NCI-H146 | AZD8835 | GDSC1 | 0.0391 | 10.0000 |
|
| NCI-H146 | AZD8931 | GDSC1 | 0.0391 | 10.0000 |
|
| NCI-H146 | BAM7 | GDSC1 | 0.0781 | 20.0000 |
|
| NCI-H146 | bardoxolone methyl | CTRP2 | 0.0020 | 66.0000 |
|
| NCI-H146 | Bax channel blocker | CTRP2 | 0.0010 | 33.0000 |
|
| NCI-H146 | BAY ACCi | GDSC1 | 0.0391 | 10.0000 |
|
| NCI-H146 | BAY AKT1 | GDSC1 | 0.0391 | 10.0000 |
|
| NCI-H146 | BAY-HDAC11_1 | GDSC1 | 0.0391 | 10.0000 |
|
| NCI-H146 | BAY-HDAC11_2 | GDSC1 | 0.0391 | 10.0000 |
|
| NCI-H146 | BAY-HDAC11_4 | GDSC1 | 0.0391 | 10.0000 |
|
| NCI-H146 | BAY-MPS-combo 2 (paclitaxel 1 uM) | GDSC1 | 0.0039 | 1.0000 |
|
| NCI-H146 | BAY-MPS-combo-1 (paclitaxel 5 uM) | GDSC1 | 0.0039 | 1.0000 |
|
| NCI-H146 | BAY-MPS1 | GDSC1 | 0.0117 | 3.0000 |
|
| NCI-H146 | BCL-LZH-4 | CTRP2 | 0.0020 | 66.0000 |
|
| NCI-H146 | Belinostat | CTRP2 | 0.0020 | 66.0000 |
|
| NCI-H146 | BI-2536 | GDSC2,CTRP2 | 0.0005 | 33.0000 |
|
| NCI-H146 | BIBF-1120 | GDSC1 | 0.0781 | 20.0000 |
|
| NCI-H146 | BIBR-1532 | GDSC2 | 0.0100 | 10.0000 |
|
| NCI-H146 | Bicalutamide | GDSC1,GDSC2 | 0.0100 | 10.0000 |
|
| NCI-H146 | birinapant | CTRP2 | 0.0020 | 66.0000 |
|
| NCI-H146 | BIX-01294 | CTRP2 | 0.0010 | 33.0000 |
|
| NCI-H146 | Bleomycin (10 uM) | GDSC1 | 0.0391 | 10.0000 |
|
| NCI-H146 | Bleomycin (50 uM) | GDSC1 | 0.1953 | 50.0000 |
|
| NCI-H146 | bleomycin A2 | CTRP2 | 0.0020 | 66.0000 |
|
| NCI-H146 | BMS-345541 | GDSC2,CTRP2 | 0.0020 | 66.0000 |
|
| NCI-H146 | BMS-536924 | GDSC1,GDSC2 | 0.0100 | 10.0000 |
|
| NCI-H146 | BMS-754807 | GDSC2 | 0.0100 | 10.0000 |
|
| NCI-H146 | Bortezomib | GDSC2 | 0.0000 | 0.0200 |
|
| NCI-H146 | Bosutinib | GDSC1,GDSC2,CTRP2 | 0.0020 | 66.0000 |
|
| NCI-H146 | BPTES | GDSC1 | 0.0391 | 10.0000 |
|
| NCI-H146 | BRD-A02303741:navitoclax (2:1 mol-mol) | CTRP2 | 0.0015 | 50.0000 |
|
| NCI-H146 | BRD-A71883111 | CTRP2 | 0.0010 | 33.0000 |
|
| NCI-H146 | BRD-A86708339 | CTRP2 | 0.0020 | 66.0000 |
|
| NCI-H146 | BRD-K03536150 | CTRP2 | 0.0081 | 270.0000 |
|
| NCI-H146 | BRD-K07442505 | CTRP2 | 0.0020 | 66.0000 |
|
| NCI-H146 | BRD-K09587429 | CTRP2 | 0.0020 | 66.0000 |
|
| NCI-H146 | BRD-K11533227 | CTRP2 | 0.0020 | 66.0000 |
|
| NCI-H146 | BRD-K13999467 | CTRP2 | 0.0020 | 66.0000 |
|
| NCI-H146 | BRD-K14844214 | CTRP2 | 0.0020 | 66.0000 |
|
| NCI-H146 | BRD-K16147474 | CTRP2 | 0.0020 | 66.0000 |
|
| NCI-H146 | BRD-K17060750 | CTRP2 | 0.0020 | 66.0000 |
|
| NCI-H146 | BRD-K19103580 | CTRP2 | 0.0020 | 66.0000 |
|
| NCI-H146 | BRD-K26531177 | CTRP2 | 0.0100 | 330.0000 |
|
| NCI-H146 | BRD-K29313308 | CTRP2 | 0.0020 | 66.0000 |
|
| NCI-H146 | BRD-K33199242 | CTRP2 | 0.0020 | 66.0000 |
|
| NCI-H146 | BRD-K34222889 | CTRP2 | 0.0017 | 57.0000 |
|
| NCI-H146 | BRD-K35604418 | CTRP2 | 0.0081 | 270.0000 |
|
| NCI-H146 | BRD-K37390332 | CTRP2 | 0.0010 | 33.0000 |
|
| NCI-H146 | BRD-K41597374 | CTRP2 | 0.0020 | 66.0000 |
|
| NCI-H146 | BRD-K45681478 | CTRP2 | 0.0020 | 66.0000 |
|
| NCI-H146 | BRD-K50799972 | CTRP2 | 0.0020 | 17.0000 |
|
| NCI-H146 | BRD-K51490254 | CTRP2 | 0.0020 | 66.0000 |
|
| NCI-H146 | BRD-K52037352 | CTRP2 | 0.0020 | 66.0000 |
|
| NCI-H146 | BRD-K55116708 | CTRP2 | 0.0020 | 17.0000 |
|
| NCI-H146 | BRD-K55473186 | CTRP2 | 0.0020 | 66.0000 |
|
| NCI-H146 | BRD-K63431240 | CTRP2 | 0.0020 | 66.0000 |
|
| NCI-H146 | BRD-K66532283 | CTRP2 | 0.0020 | 66.0000 |
|
| NCI-H146 | BRD-K71935468 | CTRP2 | 0.0025 | 83.0000 |
|
| NCI-H146 | BRD-K94991378 | CTRP2 | 0.0025 | 83.0000 |
|
| NCI-H146 | BRD-K99006945 | CTRP2 | 0.0020 | 66.0000 |
|
| NCI-H146 | BRD-M00053801 | CTRP2 | 0.0020 | 66.0000 |
|
| NCI-H146 | BRD1812 | CTRP2 | 0.0020 | 66.0000 |
|
| NCI-H146 | BRD6430 | CTRP2 | 0.0010 | 33.0000 |
|
| NCI-H146 | BRD8899 | CTRP2 | 0.0010 | 33.0000 |
|
| NCI-H146 | BRD9647 | CTRP2 | 0.0010 | 33.0000 |
|
| NCI-H146 | Brivanib, BMS-540215 | GDSC1 | 0.0781 | 20.0000 |
|
| NCI-H146 | Buparlisib | GDSC2 | 0.0100 | 10.0000 |
|
| NCI-H146 | BX795 | GDSC1,GDSC2 | 0.0100 | 10.0000 |
|
| NCI-H146 | C-75 | GDSC1 | 0.0781 | 20.0000 |
|
| NCI-H146 | C6-ceramide | CTRP2 | 0.0020 | 66.0000 |
|
| NCI-H146 | Cabozantinib | CTRP2 | 0.0020 | 66.0000 |
|
| NCI-H146 | Camptothecin | GDSC2 | 0.0001 | 0.1000 |
|
| NCI-H146 | canertinib | CTRP2 | 0.0020 | 66.0000 |
|
| NCI-H146 | CAP-232, TT-232, TLN-232 | GDSC1 | 0.0781 | 20.0000 |
|
| NCI-H146 | Capivasertib | GDSC1 | 0.1172 | 30.0000 |
|
| NCI-H146 | Carboplatin | CTRP2 | 0.0020 | 66.0000 |
|
| NCI-H146 | carboplatin:etoposide (40:17 mol-mol) | CTRP2 | 0.0014 | 47.0000 |
|
| NCI-H146 | CAY10566 | GDSC1 | 0.0100 | 2.5600 |
|
| NCI-H146 | CAY10594 | CTRP2 | 0.0020 | 66.0000 |
|
| NCI-H146 | CAY10618 | CTRP2 | 0.0010 | 33.0000 |
|
| NCI-H146 | CBB-1007 | CTRP2 | 0.0020 | 66.0000 |
|
| NCI-H146 | CCT-018159 | GDSC1,GDSC2 | 0.0100 | 10.0000 |
|
| NCI-H146 | CCT007093 | GDSC1,GDSC2 | 0.0100 | 10.0000 |
|
| NCI-H146 | CCT245232 | GDSC1 | 0.0008 | 0.2000 |
|
| NCI-H146 | CCT245467 | GDSC1 | 0.0008 | 0.2000 |
|
| NCI-H146 | CD532 | GDSC1 | 0.0200 | 5.1200 |
|
| NCI-H146 | Cediranib | GDSC2,CTRP2 | 0.0020 | 66.0000 |
|
| NCI-H146 | cerulenin | CTRP2 | 0.0045 | 150.0000 |
|
| NCI-H146 | Cetuximab | GDSC1 | 0.2570 | 65.8000 |
|
| NCI-H146 | Ch-55 | CTRP2 | 0.0020 | 66.0000 |
|
| NCI-H146 | CHEMBL1222381 | CTRP2 | 0.0081 | 270.0000 |
|
| NCI-H146 | CHIR-99021 | GDSC1,GDSC2 | 0.0100 | 10.0000 |
|
| NCI-H146 | CHM-1 | CTRP2 | 0.0005 | 16.0000 |
|
| NCI-H146 | CI-1033 | GDSC1 | 0.0781 | 20.0000 |
|
| NCI-H146 | CI-1040 | GDSC1 | 0.0391 | 10.0000 |
|
| NCI-H146 | ciclopirox | CTRP2 | 0.0020 | 66.0000 |
|
| NCI-H146 | Cisplatin | GDSC1 | 0.0117 | 6.0000 |
|
| NCI-H146 | clofarabine | CTRP2 | 0.0020 | 66.0000 |
|
| NCI-H146 | compound 1B | CTRP2 | 0.0020 | 66.0000 |
|
| NCI-H146 | CPI-613 | GDSC1 | 1.0000 | 256.0000 |
|
| NCI-H146 | CR-1-31B | CTRP2 | 0.0010 | 33.0000 |
|
| NCI-H146 | Crizotinib | GDSC2 | 0.0040 | 8.0000 |
|
| NCI-H146 | CRT0105446 | GDSC1 | 0.0391 | 10.0000 |
|
| NCI-H146 | CRT0105950 | GDSC1 | 0.0391 | 10.0000 |
|
| NCI-H146 | CRT0160829 | GDSC1 | 0.0781 | 20.0000 |
|
| NCI-H146 | Cyclophosphamide | GDSC2 | 0.0100 | 10.0000 |
|
| NCI-H146 | Cytarabine | GDSC1 | 0.0078 | 2.0000 |
|
| NCI-H146 | cytarabine hydrochloride | CTRP2 | 0.0020 | 66.0000 |
|
| NCI-H146 | CZC24832 | GDSC2 | 0.0100 | 10.0000 |
|
| NCI-H146 | Dabrafenib | GDSC1,GDSC2 | 0.0100 | 10.0000 |
|
| NCI-H146 | Dacarbazine | CTRP2 | 0.0020 | 66.0000 |
|
| NCI-H146 | Dactinomycin | GDSC2 | 0.0008 | 0.8000 |
|
| NCI-H146 | Dactolisib | GDSC1,GDSC2 | 0.0003 | 0.2500 |
|
| NCI-H146 | Daporinad | GDSC1,GDSC2,CTRP2 | 0.0001 | 2.0000 |
|
| NCI-H146 | Dasatinib | GDSC2 | 0.0020 | 2.0000 |
|
| NCI-H146 | DBeQ | CTRP2 | 0.0020 | 66.0000 |
|
| NCI-H146 | decitabine:carboplatin (1:1 mol-mol) | CTRP2 | 0.0020 | 66.0000 |
|
| NCI-H146 | decitabine:navitoclax (2:1 mol-mol) | CTRP2 | 0.0015 | 50.0000 |
|
| NCI-H146 | Dinaciclib | GDSC2,CTRP2 | 0.0010 | 66.0000 |
|
| NCI-H146 | Docetaxel | GDSC1,GDSC2,CTRP2 | 0.0000 | 66.0000 |
|
| NCI-H146 | docetaxel:tanespimycin (2:1 mol-mol) | CTRP2 | 0.0015 | 50.0000 |
|
| NCI-H146 | Doramapimod | GDSC1,GDSC2 | 0.0100 | 10.0000 |
|
| NCI-H146 | Doxorubicin | GDSC1,CTRP2 | 0.0020 | 66.0000 |
|
| NCI-H146 | doxorubicin:navitoclax (2:1 mol-mol) | CTRP2 | 0.0015 | 50.0000 |
|
| NCI-H146 | Dyrk1b_0191 | GDSC1 | 0.0391 | 10.0000 |
|
| NCI-H146 | eEF2K Inhibitor, A-484954 | GDSC1 | 0.0781 | 20.0000 |
|
| NCI-H146 | EHT-1864 | GDSC1,GDSC2 | 0.0100 | 10.0000 |
|
| NCI-H146 | Elesclomol | GDSC1,GDSC2 | 0.0002 | 0.2000 |
|
| NCI-H146 | Entinostat | GDSC2,CTRP2 | 0.0020 | 66.0000 |
|
| NCI-H146 | Entospletinib | GDSC2 | 0.0100 | 10.0000 |
|
| NCI-H146 | EphB4_9721 | GDSC1 | 0.0391 | 10.0000 |
|
| NCI-H146 | Epirubicin | GDSC2 | 0.0100 | 10.0000 |
|
| NCI-H146 | EPZ004777 | GDSC2 | 0.0100 | 10.0000 |
|
| NCI-H146 | EPZ5676 | GDSC2 | 0.0100 | 10.0000 |
|
| NCI-H146 | Erlotinib | GDSC2,CTRP2 | 0.0020 | 66.0000 |
|
| NCI-H146 | etomoxir | CTRP2 | 0.0090 | 300.0000 |
|
| NCI-H146 | Etoposide | CTRP2 | 0.0009 | 28.0000 |
|
| NCI-H146 | ETP-45835 | GDSC1 | 0.0781 | 20.0000 |
|
| NCI-H146 | Fedratinib | CTRP2 | 0.0011 | 37.0000 |
|
| NCI-H146 | FEN1_3940 | GDSC1 | 0.0391 | 10.0000 |
|
| NCI-H146 | FGFR_0939 | GDSC1 | 0.0098 | 2.5000 |
|
| NCI-H146 | FGFR_3831 | GDSC1 | 0.0391 | 10.0000 |
|
| NCI-H146 | fingolimod | CTRP2 | 0.0020 | 66.0000 |
|
| NCI-H146 | Flavopiridol | GDSC1 | 0.0100 | 2.5600 |
|
| NCI-H146 | Foretinib | GDSC2,CTRP2 | 0.0020 | 66.0000 |
|
| NCI-H146 | FS106 | GDSC1 | 0.0391 | 10.0000 |
|
| NCI-H146 | FS112 | GDSC1 | 0.0195 | 5.0000 |
|
| NCI-H146 | FTY-720 | GDSC1 | 0.0781 | 20.0000 |
|
| NCI-H146 | Fulvestrant | GDSC1,GDSC2 | 0.0010 | 10.0000 |
|
| NCI-H146 | FY012 | GDSC1 | 0.0391 | 10.0000 |
|
| NCI-H146 | FY026 | GDSC1 | 0.0391 | 10.0000 |
|
| NCI-H146 | FY069 | GDSC1 | 0.0391 | 10.0000 |
|
| NCI-H146 | GANT-61 | CTRP2 | 0.0020 | 66.0000 |
|
| NCI-H146 | GDC0810 | GDSC2 | 0.0100 | 10.0000 |
|
| NCI-H146 | Gefitinib | GDSC1,GDSC2 | 0.0020 | 2.0000 |
|
| NCI-H146 | Gemcitabine | GDSC1,GDSC2 | 0.0002 | 10.0000 |
|
| NCI-H146 | GMX-1778 | CTRP2 | 0.0000 | 0.3000 |
|
| NCI-H146 | GNE-317 | GDSC2 | 0.0100 | 10.0000 |
|
| NCI-H146 | GSK-J4 | GDSC1 | 0.1172 | 30.0000 |
|
| NCI-H146 | GSK1059615 | GDSC1,CTRP2 | 0.0010 | 33.0000 |
|
| NCI-H146 | GSK1904529A | GDSC2 | 0.0050 | 5.0000 |
|
| NCI-H146 | GSK2578215A | GDSC2 | 0.0100 | 10.0000 |
|
| NCI-H146 | GSK2606414 | GDSC2 | 0.0100 | 10.0000 |
|
| NCI-H146 | GSK269962A | GDSC1,GDSC2 | 0.0100 | 10.0000 |
|
| NCI-H146 | GSK343 | GDSC2 | 0.0010 | 1.0000 |
|
| NCI-H146 | GSK4112 | CTRP2 | 0.0020 | 66.0000 |
|
| NCI-H146 | GSK591 | GDSC2 | 0.0100 | 10.0000 |
|
| NCI-H146 | GW441756 | GDSC1,GDSC2 | 0.0020 | 2.0000 |
|
| NCI-H146 | HBX-41108 | CTRP2 | 0.0020 | 66.0000 |
|
| NCI-H146 | I-BET-762 | GDSC2,CTRP2 | 0.0020 | 66.0000 |
|
| NCI-H146 | I-BET151 | GDSC1,CTRP2 | 0.0020 | 66.0000 |
|
| NCI-H146 | I-BRD9 | GDSC2 | 0.0100 | 10.0000 |
|
| NCI-H146 | I-CBP112 | GDSC1 | 0.0391 | 10.0000 |
|
| NCI-H146 | IAP_5620 | GDSC1 | 0.0391 | 10.0000 |
|
| NCI-H146 | IAP_7638 | GDSC1 | 0.0391 | 10.0000 |
|
| NCI-H146 | Ibrutinib | GDSC2 | 0.0100 | 10.0000 |
|
| NCI-H146 | IC-87114 | GDSC1 | 0.0781 | 20.0000 |
|
| NCI-H146 | ICL1100013 | GDSC1 | 0.0781 | 20.0000 |
|
| NCI-H146 | Idelalisib | CTRP2 | 0.0020 | 66.0000 |
|
| NCI-H146 | IGFR_3801 | GDSC1 | 0.0391 | 10.0000 |
|
| NCI-H146 | IMD-0354 | GDSC1 | 0.0781 | 20.0000 |
|
| NCI-H146 | importazole | CTRP2 | 0.0061 | 200.0000 |
|
| NCI-H146 | IOX2 | GDSC1,GDSC2 | 0.0004 | 0.5000 |
|
| NCI-H146 | Ipatasertib | GDSC2 | 0.0100 | 10.0000 |
|
| NCI-H146 | IPR-456 | CTRP2 | 0.0020 | 66.0000 |
|
| NCI-H146 | Irinotecan | GDSC2 | 0.0050 | 5.0000 |
|
| NCI-H146 | ISOX | CTRP2 | 0.0010 | 33.0000 |
|
| NCI-H146 | istradefylline | CTRP2 | 0.0010 | 33.0000 |
|
| NCI-H146 | IWP-2 | GDSC2 | 0.0010 | 1.0000 |
|
| NCI-H146 | JAK1_3715 | GDSC1 | 0.0391 | 10.0000 |
|
| NCI-H146 | JAK3_7406 | GDSC1 | 0.0391 | 10.0000 |
|
| NCI-H146 | JNJ38877605 | GDSC1 | 0.0781 | 20.0000 |
|
| NCI-H146 | JNK Inhibitor VIII | GDSC1,GDSC2 | 0.0100 | 10.0000 |
|
| NCI-H146 | JQ-1:carboplatin (1:1 mol-mol) | CTRP2 | 0.0020 | 66.0000 |
|
| NCI-H146 | JQ-1:navitoclax (2:1 mol-mol) | CTRP2 | 0.0015 | 50.0000 |
|
| NCI-H146 | JQ-1:UNC0638 (2:1 mol-mol) | CTRP2 | 0.0015 | 25.0000 |
|
| NCI-H146 | JQ-1:vorinostat (2:1 mol-mol) | CTRP2 | 0.0015 | 50.0000 |
|
| NCI-H146 | JQ1 | GDSC1,GDSC2 | 0.0039 | 10.0000 |
|
| NCI-H146 | kb NB 142-70 | GDSC1 | 0.0781 | 20.0000 |
|
| NCI-H146 | KHS101 | CTRP2 | 0.0020 | 66.0000 |
|
| NCI-H146 | KIN001-042 | GDSC1 | 0.0400 | 10.2400 |
|
| NCI-H146 | Kobe2602 | GDSC1 | 0.0781 | 20.0000 |
|
| NCI-H146 | KRAS (G12C) Inhibitor-12 | GDSC2 | 0.0200 | 20.0000 |
|
| NCI-H146 | KU-0063794 | CTRP2 | 0.0020 | 66.0000 |
|
| NCI-H146 | KU-55933 | GDSC1,GDSC2 | 0.0100 | 10.0000 |
|
| NCI-H146 | KU-60019 | GDSC1 | 0.0391 | 10.0000 |
|
| NCI-H146 | KW-2449 | CTRP2 | 0.0020 | 66.0000 |
|
| NCI-H146 | L-685458 | CTRP2 | 0.0011 | 37.0000 |
|
| NCI-H146 | Lapatinib | GDSC2 | 0.0100 | 10.0000 |
|
| NCI-H146 | LCL161 | GDSC1,GDSC2 | 0.0100 | 10.0000 |
|
| NCI-H146 | LDN-193189 | GDSC1 | 0.0400 | 10.2400 |
|
| NCI-H146 | LE-135 | CTRP2 | 0.0020 | 66.0000 |
|
| NCI-H146 | Leflunomide | GDSC2 | 0.1001 | 100.0000 |
|
| NCI-H146 | Lenalidomide | GDSC1,GDSC2 | 0.0100 | 10.0000 |
|
| NCI-H146 | leptomycin B | CTRP2 | 0.0020 | 66.0000 |
|
| NCI-H146 | Lestaurtinib | GDSC1,GDSC2 | 0.0020 | 2.0000 |
|
| NCI-H146 | LGK974 | GDSC1,GDSC2 | 0.0100 | 10.0000 |
|
| NCI-H146 | LIMK1 inhibitor BMS4 | GDSC1 | 0.0781 | 20.0000 |
|
| NCI-H146 | Linsitinib | GDSC2 | 0.0100 | 10.0000 |
|
| NCI-H146 | LJI308 | GDSC2 | 0.0100 | 10.0000 |
|
| NCI-H146 | Luminespib | GDSC2 | 0.0003 | 0.2500 |
|
| NCI-H146 | LY2109761 | GDSC2 | 0.0050 | 5.0000 |
|
| NCI-H146 | manumycin A | CTRP2 | 0.0009 | 30.0000 |
|
| NCI-H146 | MCT1_6447 | GDSC1 | 0.0391 | 10.0000 |
|
| NCI-H146 | MCT4_1422 | GDSC1 | 0.0391 | 10.0000 |
|
| NCI-H146 | MetAP2 Inhibitor, A832234 | GDSC1 | 0.0100 | 2.5600 |
|
| NCI-H146 | Methotrexate | GDSC1,GDSC2,CTRP2 | 0.0008 | 66.0000 |
|
| NCI-H146 | MG-132 | GDSC2,CTRP2 | 0.0006 | 20.0000 |
|
| NCI-H146 | MGCD-265 | CTRP2 | 0.0020 | 66.0000 |
|
| NCI-H146 | MI-2 | CTRP2 | 0.0020 | 66.0000 |
|
| NCI-H146 | MIM1 | GDSC1 | 0.1562 | 40.0000 |
|
| NCI-H146 | MIRA-1 | GDSC2,CTRP2 | 0.0020 | 17.0000 |
|
| NCI-H146 | Mirin | GDSC1,GDSC2 | 0.1001 | 100.0000 |
|
| NCI-H146 | MK-1775 | GDSC2 | 0.0100 | 10.0000 |
|
| NCI-H146 | MK-2206 | GDSC1,GDSC2 | 0.0100 | 10.0000 |
|
| NCI-H146 | MK-8776 | GDSC2 | 0.0050 | 5.0000 |
|
| NCI-H146 | ML006 | CTRP2 | 0.0160 | 530.0000 |
|
| NCI-H146 | ML030 | CTRP2 | 0.0020 | 66.0000 |
|
| NCI-H146 | ML162 | CTRP2 | 0.0010 | 33.0000 |
|
| NCI-H146 | ML210 | CTRP2 | 0.0010 | 33.0000 |
|
| NCI-H146 | ML239 | CTRP2 | 0.0020 | 66.0000 |
|
| NCI-H146 | ML258 | CTRP2 | 0.0020 | 66.0000 |
|
| NCI-H146 | ML311 | CTRP2 | 0.0010 | 33.0000 |
|
| NCI-H146 | ML323 | GDSC2 | 0.0200 | 20.0000 |
|
| NCI-H146 | ML334 diastereomer | CTRP2 | 0.0041 | 130.0000 |
|
| NCI-H146 | MLN2238 | CTRP2 | 0.0010 | 33.0000 |
|
| NCI-H146 | MLN2480 | CTRP2 | 0.0020 | 66.0000 |
|
| NCI-H146 | MN-64 | GDSC2 | 0.0100 | 10.0000 |
|
| NCI-H146 | momelotinib | CTRP2 | 0.0020 | 66.0000 |
|
| NCI-H146 | Motesanib | GDSC1,GDSC2 | 0.0078 | 10.0000 |
|
| NCI-H146 | myricetin | CTRP2 | 0.0020 | 66.0000 |
|
| NCI-H146 | N22899-6-C1 | GDSC1 | 0.0391 | 10.0000 |
|
| NCI-H146 | N23918-95-7 | GDSC1 | 0.0391 | 10.0000 |
|
| NCI-H146 | N24798-49-A1 | GDSC1 | 0.0391 | 10.0000 |
|
| NCI-H146 | N9-isopropylolomoucine | CTRP2 | 0.0120 | 400.0000 |
|
| NCI-H146 | Navitoclax | GDSC1,GDSC2 | 0.0020 | 2.0000 |
|
| NCI-H146 | navitoclax:birinapant (1:1 mol-mol) | CTRP2 | 0.0010 | 33.0000 |
|
| NCI-H146 | navitoclax:gemcitabine (1:1 mol-mol) | CTRP2 | 0.0010 | 33.0000 |
|
| NCI-H146 | navitoclax:piperlongumine (1:1 mol-mol) | CTRP2 | 0.0010 | 33.0000 |
|
| NCI-H146 | navitoclax:pluripotin (1:1 mol-mol) | CTRP2 | 0.0010 | 33.0000 |
|
| NCI-H146 | navitoclax:PLX-4032 (1:1 mol-mol) | CTRP2 | 0.0010 | 33.0000 |
|
| NCI-H146 | navitoclax:sorafenib (1:1 mol-mol) | CTRP2 | 0.0015 | 50.0000 |
|
| NCI-H146 | neratinib | CTRP2 | 0.0010 | 33.0000 |
|
| NCI-H146 | Nilotinib | GDSC1,GDSC2,CTRP2 | 0.0020 | 66.0000 |
|
| NCI-H146 | nintedanib | CTRP2 | 0.0020 | 66.0000 |
|
| NCI-H146 | Niraparib | GDSC2 | 0.0100 | 10.0000 |
|
| NCI-H146 | NSC319726 | GDSC1 | 0.0010 | 0.2560 |
|
| NCI-H146 | NU7441 | GDSC1,GDSC2 | 0.0078 | 10.0000 |
|
| NCI-H146 | Nutlin-3a | GDSC1,GDSC2 | 0.0100 | 10.0000 |
|
| NCI-H146 | NVP-231 | CTRP2 | 0.0020 | 66.0000 |
|
| NCI-H146 | NVP-ADW742 | GDSC2,CTRP2 | 0.0020 | 66.0000 |
|
| NCI-H146 | NVP-BSK805 | CTRP2 | 0.0020 | 66.0000 |
|
| NCI-H146 | NVP-TAE684 | CTRP2 | 0.0020 | 66.0000 |
|
| NCI-H146 | O-6-benzylguanine | CTRP2 | 0.0020 | 66.0000 |
|
| NCI-H146 | Obatoclax Mesylate | CTRP2 | 0.0020 | 66.0000 |
|
| NCI-H146 | OF-1 | GDSC2 | 0.0100 | 10.0000 |
|
| NCI-H146 | Olaparib | GDSC1,GDSC2 | 0.0100 | 10.0000 |
|
| NCI-H146 | oligomycin A | CTRP2 | 0.0010 | 33.0000 |
|
| NCI-H146 | OSI-027 | GDSC2,CTRP2 | 0.0020 | 66.0000 |
|
| NCI-H146 | Osimertinib | GDSC2 | 0.0010 | 1.0000 |
|
| NCI-H146 | OTX015 | GDSC2 | 0.0100 | 10.0000 |
|
| NCI-H146 | ouabain | CTRP2 | 0.0081 | 270.0000 |
|
| NCI-H146 | Oxaliplatin | GDSC2 | 0.0100 | 10.0000 |
|
| NCI-H146 | P22077 | GDSC2 | 0.0100 | 10.0000 |
|
| NCI-H146 | Paclitaxel | GDSC2 | 0.0001 | 0.1000 |
|
| NCI-H146 | Palbociclib | GDSC1,GDSC2 | 0.0040 | 4.0000 |
|
| NCI-H146 | Panobinostat | GDSC1 | 0.0040 | 1.0240 |
|
| NCI-H146 | PARP_0108 | GDSC1 | 0.0098 | 2.5000 |
|
| NCI-H146 | PARP_9482 | GDSC1 | 0.0098 | 2.5000 |
|
| NCI-H146 | PARP_9495 | GDSC1 | 0.0098 | 2.5000 |
|
| NCI-H146 | PCI-34051 | GDSC2 | 0.0100 | 10.0000 |
|
| NCI-H146 | PD0325901 | GDSC1,GDSC2 | 0.0010 | 2.5000 |
|
| NCI-H146 | PD173074 | GDSC1,GDSC2 | 0.0078 | 10.0000 |
|
| NCI-H146 | Pemetrexed | GDSC1 | 0.0100 | 2.5600 |
|
| NCI-H146 | Pevonedistat | GDSC1,GDSC2 | 0.0039 | 10.0000 |
|
| NCI-H146 | PF-00299804 | GDSC1 | 0.0781 | 20.0000 |
|
| NCI-H146 | PF-3758309 | CTRP2 | 0.0020 | 66.0000 |
|
| NCI-H146 | PF-4708671 | GDSC1,GDSC2 | 0.0100 | 10.0000 |
|
| NCI-H146 | PF-750 | CTRP2 | 0.0081 | 270.0000 |
|
| NCI-H146 | PFI-1 | GDSC1,GDSC2 | 0.0100 | 10.0000 |
|
| NCI-H146 | PFI3 | GDSC1,GDSC2 | 0.0100 | 10.0000 |
|
| NCI-H146 | PI3Ka_4409 | GDSC1 | 0.0391 | 10.0000 |
|
| NCI-H146 | Picolinici-acid | GDSC2 | 0.0100 | 10.0000 |
|
| NCI-H146 | Pictilisib | GDSC1,GDSC2,CTRP2 | 0.0020 | 66.0000 |
|
| NCI-H146 | pifithrin-alpha | CTRP2 | 0.0071 | 230.0000 |
|
| NCI-H146 | pifithrin-mu | CTRP2 | 0.0010 | 33.0000 |
|
| NCI-H146 | Pilaralisib | GDSC1 | 0.0781 | 20.0000 |
|
| NCI-H146 | Piperlongumine | GDSC1,GDSC2 | 0.0100 | 10.0000 |
|
| NCI-H146 | Platin | CTRP2 | 0.0020 | 66.0000 |
|
| NCI-H146 | PLK_6522 | GDSC1 | 0.0024 | 0.6250 |
|
| NCI-H146 | pluripotin | CTRP2 | 0.0010 | 33.0000 |
|
| NCI-H146 | PLX-4720 | GDSC1,GDSC2 | 0.0100 | 10.0000 |
|
| NCI-H146 | PRIMA-1MET | GDSC2 | 0.0300 | 30.0000 |
|
| NCI-H146 | procarbazine | CTRP2 | 0.0020 | 66.0000 |
|
| NCI-H146 | PRT062607 | GDSC2 | 0.0100 | 10.0000 |
|
| NCI-H146 | purmorphamine | CTRP2 | 0.0046 | 150.0000 |
|
| NCI-H146 | PYR-41 | CTRP2 | 0.0020 | 66.0000 |
|
| NCI-H146 | Pyridostatin | GDSC2 | 0.0100 | 10.0000 |
|
| NCI-H146 | RAF_9304 | GDSC1 | 0.0391 | 10.0000 |
|
| NCI-H146 | Rapamycin | GDSC2,CTRP2 | 0.0001 | 33.0000 |
|
| NCI-H146 | Refametinib | GDSC1,GDSC2 | 0.0100 | 10.0000 |
|
| NCI-H146 | Regorafenib | CTRP2 | 0.0020 | 66.0000 |
|
| NCI-H146 | Ribociclib | GDSC2 | 0.0020 | 2.0000 |
|
| NCI-H146 | RITA | CTRP2 | 0.0010 | 33.0000 |
|
| NCI-H146 | RO-3306 | GDSC1,GDSC2 | 0.0100 | 10.0000 |
|
| NCI-H146 | rTRAIL | GDSC1 | 0.0004 | 0.1000 |
|
| NCI-H146 | RU-SKI 43 | GDSC1 | 0.0781 | 20.0000 |
|
| NCI-H146 | Rucaparib | GDSC1,GDSC2 | 0.0050 | 5.0000 |
|
| NCI-H146 | Ruxolitinib | GDSC2 | 0.0100 | 10.0000 |
|
| NCI-H146 | RVX-208 | GDSC2 | 0.0100 | 10.0000 |
|
| NCI-H146 | Sabutoclax | GDSC2 | 0.0100 | 10.0000 |
|
| NCI-H146 | Sapitinib | GDSC2 | 0.0050 | 5.0000 |
|
| NCI-H146 | Savolitinib | GDSC2 | 0.0010 | 1.0000 |
|
| NCI-H146 | SB-225002 | CTRP2 | 0.0011 | 37.0000 |
|
| NCI-H146 | SB-525334 | CTRP2 | 0.0020 | 66.0000 |
|
| NCI-H146 | SB216763 | GDSC1,GDSC2 | 0.0100 | 10.0000 |
|
| NCI-H146 | SB505124 | GDSC1,GDSC2 | 0.0100 | 20.0000 |
|
| NCI-H146 | SB590885 | GDSC1,GDSC2 | 0.0050 | 5.0000 |
|
| NCI-H146 | SCH-529074 | CTRP2 | 0.0010 | 33.0000 |
|
| NCI-H146 | SCH-79797 | CTRP2 | 0.0011 | 37.0000 |
|
| NCI-H146 | SCH772984 | GDSC2 | 0.0050 | 5.0000 |
|
| NCI-H146 | Selumetinib | GDSC1,GDSC2 | 0.0100 | 10.0000 |
|
| NCI-H146 | selumetinib:GDC-0941 (4:1 mol-mol) | CTRP2 | 0.0051 | 170.0000 |
|
| NCI-H146 | selumetinib:JQ-1 (4:1 mol-mol) | CTRP2 | 0.0051 | 170.0000 |
|
| NCI-H146 | selumetinib:PLX-4032 (8:1 mol-mol) | CTRP2 | 0.0046 | 150.0000 |
|
| NCI-H146 | selumetinib:tretinoin (2:1 mol-mol) | CTRP2 | 0.0061 | 200.0000 |
|
| NCI-H146 | Sepantronium bromide | GDSC2,CTRP2 | 0.0000 | 10.0000 |
|
| NCI-H146 | Serdemetan | GDSC1,GDSC2,CTRP2 | 0.0010 | 33.0000 |
|
| NCI-H146 | serdemetan:SCH-529074 (1:1 mol-mol) | CTRP2 | 0.0010 | 33.0000 |
|
| NCI-H146 | SGC0946 | GDSC1,GDSC2 | 0.0005 | 0.5000 |
|
| NCI-H146 | SGX-523 | CTRP2 | 0.0020 | 66.0000 |
|
| NCI-H146 | sirolimus:bortezomib (250:1 mol-mol) | CTRP2 | 0.0005 | 17.0000 |
|
| NCI-H146 | skepinone-L | CTRP2 | 0.0020 | 66.0000 |
|
| NCI-H146 | SL0101 | GDSC1,GDSC2 | 0.0100 | 10.0000 |
|
| NCI-H146 | SN-38 | GDSC1,GDSC2,CTRP2 | 0.0000 | 10.0000 |
|
| NCI-H146 | SNX-2112 | CTRP2 | 0.0010 | 33.0000 |
|
| NCI-H146 | SNX-2112:bortezomib (250:1 mol-mol) | CTRP2 | 0.0005 | 17.0000 |
|
| NCI-H146 | Sorafenib | GDSC2,CTRP2 | 0.0020 | 66.0000 |
|
| NCI-H146 | Sphingosine Kinase 1 Inhibitor II | GDSC1 | 0.0100 | 2.5600 |
|
| NCI-H146 | Staurosporine | GDSC2 | 0.0078 | 2.0000 |
|
| NCI-H146 | StemRegenin 1 | CTRP2 | 0.0020 | 66.0000 |
|
| NCI-H146 | STF-31 | CTRP2 | 0.0020 | 66.0000 |
|
| NCI-H146 | SU11274 | GDSC1 | 0.0400 | 10.2400 |
|
| NCI-H146 | SZ4TA2 | CTRP2 | 0.0020 | 66.0000 |
|
| NCI-H146 | tacedinaline | CTRP2 | 0.0010 | 33.0000 |
|
| NCI-H146 | Talazoparib | GDSC1,GDSC2 | 0.0100 | 10.0000 |
|
| NCI-H146 | Tamoxifen | GDSC1,GDSC2 | 0.0100 | 10.0000 |
|
| NCI-H146 | tandutinib | CTRP2 | 0.0020 | 66.0000 |
|
| NCI-H146 | Tanespimycin | GDSC1,GDSC2,CTRP2 | 0.0010 | 33.0000 |
|
| NCI-H146 | tanespimycin:bortezomib (250:1 mol-mol) | CTRP2 | 0.0005 | 17.0000 |
|
| NCI-H146 | TANK_1366 | GDSC1 | 0.0098 | 2.5000 |
|
| NCI-H146 | Taselisib | GDSC2 | 0.0100 | 10.0000 |
|
| NCI-H146 | Telomerase Inhibitor IX | GDSC2,CTRP2 | 0.0010 | 33.0000 |
|
| NCI-H146 | Temozolomide | GDSC1,GDSC2 | 0.0300 | 30.0000 |
|
| NCI-H146 | Temsirolimus | GDSC1,GDSC2 | 0.0008 | 1.0000 |
|
| NCI-H146 | Tenovin-6 | GDSC1 | 0.0781 | 20.0000 |
|
| NCI-H146 | tipifarnib-P1 | CTRP2 | 0.0010 | 33.0000 |
|
| NCI-H146 | tivantinib | CTRP2 | 0.0020 | 66.0000 |
|
| NCI-H146 | Topotecan | CTRP2 | 0.0020 | 66.0000 |
|
| NCI-H146 | Torin 2 | GDSC1 | 0.0781 | 20.0000 |
|
| NCI-H146 | Tozasertib | GDSC2 | 0.0050 | 5.0000 |
|
| NCI-H146 | Trametinib | GDSC1,GDSC2,CTRP2 | 0.0010 | 66.0000 |
|
| NCI-H146 | Tretinoin | GDSC1,GDSC2 | 0.0100 | 10.0000 |
|
| NCI-H146 | tretinoin:navitoclax (4:1 mol-mol) | CTRP2 | 0.0025 | 83.0000 |
|
| NCI-H146 | Trichostatin A | GDSC1 | 0.0040 | 1.0240 |
|
| NCI-H146 | triptolide | CTRP2 | 0.0000 | 0.3000 |
|
| NCI-H146 | TTK_3146 | GDSC1 | 0.0391 | 10.0000 |
|
| NCI-H146 | TW 37 | GDSC1,CTRP2 | 0.0010 | 33.0000 |
|
| NCI-H146 | TWS119 | GDSC1 | 0.0781 | 20.0000 |
|
| NCI-H146 | Ulixertinib | GDSC2 | 0.0100 | 10.0000 |
|
| NCI-H146 | UNC0321 | CTRP2 | 0.0010 | 33.0000 |
|
| NCI-H146 | UNC0638 | GDSC1 | 0.0781 | 20.0000 |
|
| NCI-H146 | UNC0638:navitoclax (1:1 mol-mol) | CTRP2 | 0.0010 | 17.0000 |
|
| NCI-H146 | UNC0642 | GDSC1 | 0.0020 | 0.5000 |
|
| NCI-H146 | UNC1215 | GDSC1 | 0.0039 | 1.0000 |
|
| NCI-H146 | Uprosertib | GDSC2 | 0.0100 | 10.0000 |
|
| NCI-H146 | VAF-347 | CTRP2 | 0.0020 | 66.0000 |
|
| NCI-H146 | valdecoxib | CTRP2 | 0.0180 | 600.0000 |
|
| NCI-H146 | VE-822 | GDSC2 | 0.0050 | 5.0000 |
|
| NCI-H146 | VE821 | GDSC2 | 0.0100 | 10.0000 |
|
| NCI-H146 | Veliparib | GDSC1,GDSC2,CTRP2 | 0.0010 | 33.0000 |
|
| NCI-H146 | Venetoclax | GDSC2 | 0.0010 | 1.0000 |
|
| NCI-H146 | Venotoclax | GDSC1 | 0.0010 | 0.2560 |
|
| NCI-H146 | VER-155008 | CTRP2 | 0.0011 | 37.0000 |
|
| NCI-H146 | Vinblastine | GDSC1 | 0.0004 | 0.1000 |
|
| NCI-H146 | Vincristine | CTRP2 | 0.0041 | 130.0000 |
|
| NCI-H146 | Vinorelbine | GDSC2 | 0.0001 | 0.1000 |
|
| NCI-H146 | Vismodegib | GDSC1,GDSC2 | 0.0100 | 10.0000 |
|
| NCI-H146 | Vorinostat | GDSC1,GDSC2,CTRP2 | 0.0010 | 33.0000 |
|
| NCI-H146 | vorinostat:carboplatin (1:1 mol-mol) | CTRP2 | 0.0020 | 66.0000 |
|
| NCI-H146 | vorinostat:navitoclax (4:1 mol-mol) | CTRP2 | 0.0010 | 33.0000 |
|
| NCI-H146 | Voxtalisib | GDSC1 | 0.0781 | 20.0000 |
|
| NCI-H146 | VX-11e | GDSC2 | 0.0100 | 10.0000 |
|
| NCI-H146 | VX-702 | GDSC1 | 0.0078 | 2.0000 |
|
| NCI-H146 | WAY-362450 | CTRP2 | 0.0020 | 66.0000 |
|
| NCI-H146 | Wee1 Inhibitor | GDSC1,GDSC2 | 0.0078 | 10.0000 |
|
| NCI-H146 | WEHI-539 | GDSC2 | 0.0100 | 10.0000 |
|
| NCI-H146 | WIKI4 | GDSC2 | 0.0100 | 10.0000 |
|
| NCI-H146 | Wnt-C59 | GDSC1,GDSC2 | 0.0100 | 10.0000 |
|
| NCI-H146 | WP1130 | CTRP2 | 0.0020 | 66.0000 |
|
| NCI-H146 | WYE-125132 | GDSC1 | 0.0400 | 10.2400 |
|
| NCI-H146 | WZ4003 | GDSC2 | 0.0100 | 10.0000 |
|
| NCI-H146 | XAV939 | GDSC1,GDSC2 | 0.0050 | 5.0000 |
|
| NCI-H146 | YK-4-279 | GDSC1,GDSC2 | 0.0100 | 10.0000 |
|
| NCI-H146 | zebularine | CTRP2 | 0.0180 | 590.0000 |
|
| NCI-H146 | ZL049 | GDSC1 | 0.0391 | 10.0000 |
|
| NCI-H146 | ZL109 | GDSC1 | 0.0391 | 10.0000 |
|
| NCI-H146 | ZM447439 | GDSC1,GDSC2 | 0.0100 | 10.0000 |
|
IC50
IC50 indicates how much drug dosage is needed to inhibit the cells by 50%, in vitro, compared to the control well.
Drugs with highest and lowest IC50
Drugs with highest and lowest IC50
IC90
IC90 indicates how much drug dosage is needed to inhibit the cells by 90%, in vitro, compared to the control well.
Drugs with highest and lowest IC90
Drugs with highest and lowest IC90
AUC
AUC represents the area under a dose-response curve, where 0% indicates no activity and 100% indicates that a drug completely inhibits the cells across testing dosages.
Drugs with highest and lowest AUC
Drugs with highest and lowest AUC